TriSalus Life Sciences, Inc.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
TLSI$2.85-11.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 15th day of May, 2025.
| TriSalus Life Sciences, Inc. | ||
| By: | /s/ James Young | |
| Name: | James Young | |
| Title: | Chief Financial Officer | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.